Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products > 300 > 

300-62-9

Products Categories

Basic Information
CAS No.: 300-62-9
Name: D/L-AMPHETAMINE HYDROCHLORIDE
Article Data: 117
Molecular Structure:
Molecular Structure of 300-62-9 (D/L-AMPHETAMINE HYDROCHLORIDE)
Formula: C9H13N
Molecular Weight: 135.209
Synonyms: Benzeneethanamine,a-methyl-, (?à)-;Phenethylamine, a-methyl-, (?à)- (8CI);1-Benzylethylamine;1-Methyl-2-phenylethylamine;1-Phenyl-2-aminopropane;1-Phenyl-2-propanamine;1-Phenyl-2-propylamine;2-Amino-1-phenylpropane;3-Phenyl-2-propylamine;Actedron;Adderall;Adipan;Amfetamine;Amphetamine;Anorexine;Benzedrine;Desoxynorephedrine;Fenopromin;Isoamyne;Mecodrin;NSC 27159;Norephedrane;Obesin;Oktedrin;Percomon;Phenamine;Profamina;Propisamine;Raphetamine;SLI 381;Simpatina;Sympamine;Sympatedrine;dl-a-Methylphenethylamine;a-Methyl-b-phenylethylamine;a-Methylbenzeneethanamine;a-Methylphenylethylamine;b-Phenylisopropylamine;
EINECS: 206-096-2
Density: 0.946 g/cm3
Melting Point: 146 °C
Boiling Point: 201.5 °C at 760 mmHg
Flash Point: 87.4 °C
Hazard Symbols: F,T
Risk Codes: 11-23/24/25-39/23/24/25
Safety: 16-36/37-45-7
PSA: 26.02000
LogP: 2.27660
  • Display:default sort

    New supplier

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

Consensus Reports

Reported in EPA TSCA Inventory. EPA Extremely Hazardous Substances List.

Specification

The Benzedrine is an organic compound with the formula C9H13N. The IUPAC name of this chemical is 1-phenylpropan-2-amine. With the CAS registry number 300-62-9, it is also named as (2S)-1-Phenylpropan-2-amin. The product's classification codes are Adrenergic agents; Adrenergic uptake inhibitors; Autonomic Agents; Central Nervous System Agents; Central nervous system stimulants; Dopamine agents; Dopamine uptake inhibitors; Drug / Therapeutic Agent; Human Data; Mutation data; Neurotransmitter Agents; Neurotransmitter Uptake Inhibitors; Peripheral Nervous System Agents; Reproductive Effect; Sympathomimetics. Besides, it was used to enlarge nasal and bronchial passages and it is closely related to other stimulants produced later, such as dextroamphetamine and methamphetamine.

Physical properties about Benzedrine are: (1)ACD/LogP: 1.81; (2)ACD/LogD (pH 5.5): -1.28; (3)ACD/LogD (pH 7.4): -0.63; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 1; (8)#H bond acceptors: 1; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 3; (11)Polar Surface Area: 3.24 Å2; (12)Index of Refraction: 1.527; (13)Molar Refractivity: 43.92 cm3; (14)Molar Volume: 142.8 cm3; (15)Polarizability: 17.41×10-24cm3; (16)Surface Tension: 36.1 dyne/cm; (17)Density: 0.946 g/cm3; (18)Flash Point: 87.4 °C; (19)Enthalpy of Vaporization: 43.77 kJ/mol; (20)Boiling Point: 201.5 °C at 760 mmHg; (21)Vapour Pressure: 0.307 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: N[C@H](Cc1ccccc1)C
(2)InChI: InChI=1/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1
(3)InChIKey: KWTSXDURSIMDCE-QMMMGPOBBF
(4)Std. InChI: InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1
(5)Std. InChIKey: KWTSXDURSIMDCE-QMMMGPOBSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo subcutaneous 20mg/kg (20mg/kg)   "Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 149, 1948.
guinea pig LDLo oral 200mg/kg (200mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: EXCITEMENT
Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 128, Pg. 680, 1938.
guinea pig LDLo parenteral 20mg/kg (20mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: EXCITEMENT
Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 128, Pg. 680, 1938.
guinea pig LDLo subcutaneous 20mg/kg (20mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: EXCITEMENT
Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 128, Pg. 680, 1938.
mammal (species unspecified) LD50 intraperitoneal 65mg/kg (65mg/kg)   Biochimie. Vol. 63, Pg. 495, 1981.
mammal (species unspecified) LD50 oral 135mg/kg (135mg/kg)   Biochimie. Vol. 63, Pg. 495, 1981.
man LDLo unreported 2206ug/kg (2.206mg/kg)   "Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970.
monkey LDLo subcutaneous 20mg/kg (20mg/kg)   "Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 149, 1948.
mouse LD50 intraperitoneal 5500ug/kg (5.5mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 161, Pg. 206, 1966.
mouse LD50 intravenous 15mg/kg (15mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 146, Pg. 392, 1963.
mouse LD50 oral 21mg/kg (21mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 23, Pg. 810, 1973.
mouse LD50 subcutaneous 15mg/kg (15mg/kg)   Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 4, Pg. 139, 1945.
mouse LD50 unreported 8800ug/kg (8.8mg/kg)   Acta Physiologica Academiae Scientiarum Hungaricae. Vol. 32, Pg. 377, 1967.
rabbit LDLo intravenous 25mg/kg (25mg/kg)   "Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 149, 1948.
rabbit LDLo subcutaneous 20mg/kg (20mg/kg)   "Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 149, 1948.
rat LD50 oral 30mg/kg (30mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 23, Pg. 810, 1973.
rat LD50 subcutaneous 180mg/kg (180mg/kg) BEHAVIORAL: EXCITEMENT Journal of Pharmacology and Experimental Therapeutics. Vol. 85, Pg. 119, 1945.
rat LDLo intraperitoneal 23mg/kg (23mg/kg)   Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 195, Pg. 647, 1940.
rat LDLo intravenous 20mg/kg (20mg/kg)   "Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 101, 1948.